Loading clinical trials...
Loading clinical trials...
A Prospective, Post-Market, Multicenter, Randomized Controlled Trial to Compare the Performance of the EndoRotor® System Versus Conventional Endoscopic Techniques for Direct Endoscopic Necrosectomy of Walled Off Necrosis - The RESOlVE Trial
Conditions
Interventions
EndoRotor® System (Interscope, Inc., Northbridge, MA USA),
Conventional endoscopic devices (according to standards of care)
Locations
12
United States
University of Alabama Medical Center
Birmingham, Alabama, United States
California Pacific Medical Center
San Francisco, California, United States
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Copenhagen University Hospital
Hvidovre, Denmark
Evangelical Hospital
Düsseldorf, Germany
University of Frankfurt
Frankfurt, Germany
Start Date
September 2, 2022
Primary Completion Date
August 28, 2026
Completion Date
February 1, 2027
Last Updated
August 8, 2025
NCT06651580
NCT06553651
NCT07395778
NCT07171112
NCT07153809
NCT03684278
Lead Sponsor
Erasmus Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions